Literature DB >> 28468000

Protective Function of Ahnak1 in Vascular Healing after Wire Injury.

Nadine Haase1, Constantin Rüder, Hannelore Haase, Stefanie Kamann, Michiyoshi Kouno, Ingo Morano, Ralf Dechend, Dietlind Zohlnhöfer, Tobias Haase.   

Abstract

AIM: Vascular remodeling following injury substantially accounts for restenosis and adverse clinical outcomes. In this study, we investigated the role of the giant scaffold protein Ahnak1 in vascular healing after endothelial denudation of the murine femoral artery.
METHODS: The spatiotemporal expression pattern of Ahnak1 and Ahnak2 was examined using specific antibodies and real-time quantitative PCR. Following wire-mediated endothelial injury of Ahnak1-deficient mice and wild-type (WT) littermates, the processes of vascular healing were analyzed.
RESULTS: Ahnak1 and Ahnak2 showed a mutually exclusive vascular expression pattern, with Ahnak1 being expressed in the endothelium and Ahnak2 in the medial cells in naïve WT arteries. After injury, a marked increase of Ahnak1- and Ahnak2-positive cells at the lesion site became evident. Both proteins showed a strong upregulation in neointimal cells 14 days after injury. Ahnak1-deficient mice showed delayed vascular healing and dramatically impaired re-endothelialization that resulted in prolonged adverse vascular remodeling, when compared to the WT littermates.
CONCLUSION: The large scaffold and adaptor proteins Ahnak1 and Ahnak2 exhibit differential expression patterns and functions in naïve and injured arteries. Ahnak1 plays a nonredundant protective role in vascular healing.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Endothelialization; Neointima formation; Vascular remodeling

Mesh:

Substances:

Year:  2017        PMID: 28468000     DOI: 10.1159/000464287

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  3 in total

1.  AHNAK2 Promotes Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cells via the TGF-β/Smad3 Pathway.

Authors:  Gang Liu; Zhongliang Guo; Qian Zhang; Zhongmin Liu; Dongyi Zhu
Journal:  Onco Targets Ther       Date:  2020-12-16       Impact factor: 4.147

Review 2.  The Obscure Potential of AHNAK2.

Authors:  Mohamed Zardab; Konstantinos Stasinos; Richard P Grose; Hemant M Kocher
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

3.  Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.

Authors:  Dong-Wei Wang; Hai-Zheng Zheng; Na Cha; Xiao-Jie Zhang; Min Zheng; Ming-Ming Chen; Li-Xiang Tian
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.